insights_auto
Why is AXGN up 15,21%?
Dive Deeperchevron_right
AXGN:NASDAQ
AxoGen, Inc Common Stock
58,63 USD
arrow_upward
+15,21%(+7,74) 1D
58,32 USD
arrow_downward
-0,53% (-0,31)bedtimeAfter hours
Closed: 11-ноя., 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AXGN...
Open
50,93 USD
High
59,72 USD
Low
50,62 USD
Mkt. cap
3,50 млд
Avg. vol.
1,81 млн
Volume
4,41 млн
52-wk high
59,72 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
Open
50,93 USD
High
59,72 USD
Low
50,62 USD
Mkt. cap
3,50 млд
Avg. vol.
1,81 млн
Volume
4,41 млн
52-wk high
59,72 USD
52-wk low
23,00 USD
EPS
-0,68 USD
Beta
1,21
Shares outstanding
59,73 млн
No. of employees
622
News stories
From web sources and news partners
Investing.com
·
4 саат мурун
Axogen stock hits 52-week high at $52.92
Investing.com
·
6 саат мурун
AxoGen at Canaccord forum: growth plan widens beyond nerve repair
Investing.com Canada
·
2 күн мурун
Form 8K Axogen Inc For: 9 November By Investing.com
Profile
Axogen is a developer of surgical solutions, including human tissue grafts, based in Tampa, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology Avance to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available nerve allograft approved by the Food and Drug Administration for clinical use. Wikipedia
About AxoGen, Inc Common Stock
CEO-
Employees622
Founded2002
HeadquartersАлачуа, Флорида, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Websiteaxogeninc.com